Company
Headquarters: Liuzhou, China
Employees: 4,706
CN¥6.86 Billion
CNY as of July 1, 2025
US$957.0 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $88.11 B |
| Cencora, Inc. | $56.44 B |
| Cardinal Health, Inc. | $38.66 B |
| Henry Schein, Inc. | $9.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Guangxi Liuzhou Pharmaceutical Co., Ltd. engages in the distribution and retail of pharmaceutical products in China. The company was founded in 1981 and is based in Liuzhou, China. Guangxi Liuzhou Pharmaceutical Co., Ltd. is a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥20.72 B |
| EBITDA | CN¥1.28 B |
| Gross Profit TTM | CN¥2.31 B |
| Profit Margin | 4.01% |
| Operating Margin | 6.79% |
| Quarterly Revenue Growth | -7.90% |
Guangxi Liuzhou Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603368 wb_incandescent